期刊
INTERNAL MEDICINE JOURNAL
卷 53, 期 8, 页码 1306-1310出版社
WILEY
DOI: 10.1111/imj.16142
关键词
pharmaceuticals; clinical research; clinical practice; funding; reimbursement; drug development
Novel medicines are rapidly entering the market and being used alone or in combination to treat various illnesses. This article provides a primer to help practitioners understand the changing therapeutic landscape and its impact on evidence generation, access to interventions, patient experience, and quality of care.
Novel medicines are entering the market rapidly and are increasingly being used alone or in combination to treat illnesses of every sort. While transforming the lives of many patients, these new therapies have also forced us to reconsider the way we evaluate, use and fund medicines. This article offers a primer to help practitioners understand how the therapeutic landscape is changing and how this might impact the evidence generation, access to interventions, patient experience and quality of care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据